Group sequential crossover trial designs with strong control of the familywise error rate
From MaRDI portal
Publication:4689943
DOI10.1080/07474946.2018.1466528zbMath1403.62200arXiv1710.03492OpenAlexW2963880075WikidataQ58587422 ScholiaQ58587422MaRDI QIDQ4689943
Michael J. Grayling, Adrian P. Mander, James M. S. Wason
Publication date: 22 October 2018
Published in: Sequential Analysis (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/1710.03492
Applications of statistics to biology and medical sciences; meta analysis (62P10) Generalized linear models (logistic models) (62J12) Sequential statistical design (62L05)
Uses Software
Cites Work
- Unnamed Item
- Unnamed Item
- Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis
- A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection
- On Deriving the Inverse of a Sum of Matrices
- A group sequential approach to crossover trials for average bioequivalence
- Ethical considerations concerning treatment allocation in drug development trials
This page was built for publication: Group sequential crossover trial designs with strong control of the familywise error rate